Trademark: 77298577
Word
PLESAPIX
Status
Dead
Status Code
606
Status Date
Monday, October 25, 2010
Serial Number
77298577
Mark Type
4000
Filing Date
Monday, October 8, 2007
Published for Opposition
Tuesday, July 1, 2008
Abandoned Date
Monday, October 25, 2010

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Trademark Events
Oct 25, 2010
Abandonment Notice Mailed - No Use Statement Filed
Oct 25, 2010
Abandonment - No Use Statement Filed
Mar 5, 2010
Extension 3 Granted
Feb 22, 2010
Extension 3 Filed
Feb 22, 2010
Teas Extension Received
Dec 28, 2009
Attorney Revoked And/Or Appointed
Dec 28, 2009
Teas Revoke/Appoint Attorney Received
Aug 24, 2009
Extension 2 Granted
Aug 20, 2009
Extension 2 Filed
Aug 20, 2009
Teas Extension Received
Feb 18, 2009
Extension 1 Granted
Feb 4, 2009
Extension 1 Filed
Feb 18, 2009
Case Assigned To Intent To Use Paralegal
Feb 4, 2009
Teas Extension Received
Sep 23, 2008
Noa Mailed - Sou Required From Applicant
Jul 1, 2008
Published For Opposition
Jun 11, 2008
Notice Of Publication
May 23, 2008
Law Office Publication Review Completed
May 23, 2008
Assigned To Lie
May 23, 2008
Approved For Pub - Principal Register
May 2, 2008
Assigned To Examiner
May 1, 2008
Teas/Email Correspondence Entered
May 1, 2008
Correspondence Received In Law Office
May 1, 2008
Teas Response To Office Action Received
Dec 17, 2007
Non-Final Action Mailed
Dec 17, 2007
Non-Final Action Written
Dec 13, 2007
Assigned To Examiner
Oct 11, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24